The plausible timeline, reconstructed from Lilly's disclosed trial schedule and standard regulatory review windows, looks roughly like this: Q2-Q3 2026: TRIUMPH-1 and TRIUMPH-2 readouts
Proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-), interleukin-1 beta, and interferon-gamma (IFN-), promote ROS production, while ROS scavengers such as pyrrolidine dithiocarbamate and N-acetyl-cysteine (NAC) can reduce the ROS levels induced by these cytokines 14
First, most human data comes from small cosmetic studies focused on efficacy endpoints such as wrinkle depth or skin firmness, not from trials designed and powered to detect rare adverse events
If the tone across your shoulders and back is what you actually want to change, the wash is the one product you already use everywhere without having to remember it
Your GP can discuss evidence-based treatments and refer you to specialist ADHD services for comprehensive assessment and management